Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 5/20 | 0.60 |
| ▸ | CES1 | P23141 | 4/20 | 0.55 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.54 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1080623 | 0.97 | CES2 (0.64) | CES2CES1FFAR4FFAR1 | |
| SCHEMBL10507922 | 0.97 | CES2 (0.64) | CES2CES1FFAR4FFAR1 | |
| SCHEMBL1712783 | 0.97 | CES2 (0.64) | CES2CES1FFAR4FFAR1 | |
| SCHEMBL5311779 | 0.97 | CES2 (0.64) | CES2CES1FFAR4FFAR1 | |
| SCHEMBL5307291 | 0.97 | CES2 (0.64) | CES2CES1FFAR4FFAR1 | |
| SCHEMBL5311427 | 0.97 | CES2 (0.64) | CES2CES1FFAR4FFAR1 | |
| SCHEMBL3126476 | 0.92 | — | — | |
| Phosphoric Acid SCHEMBL2936662 | 0.89 | CES2 (0.55) | CES2FFAR4FFAR1 | |
| Phosphoric Acid SCHEMBL11141469 | 0.89 | CES2 (0.55) | CES2FFAR4FFAR1 | |
| SCHEMBL4856778 | 0.84 | CES2 (0.60) | CES2CES1AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117986087-A | Method for preparing 1, 3-propylene glycol and by-producing 4-hetero-oxo-heptanediol | 江苏扬农化工集团有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-117362152-A | Preparation method and product of 1, 3-propylene glycol | 江苏扬农化工集团有限公司 | 2024-01-09 | — | — | CN | claimed |
| CN-114249633-B | Method for separating and purifying 1, 3-propylene glycol | 江苏扬农化工集团有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-114276216-B | Method for removing aldehyde impurities in 1, 3-propylene glycol | 江苏扬农化工集团有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-118702542-A | Preparation method of1, 3-propanediol | 江苏扬农化工集团有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-117986087-A | Method for preparing 1, 3-propylene glycol and by-producing 4-hetero-oxo-heptanediol | 江苏扬农化工集团有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117986087-A | Method for preparing 1, 3-propylene glycol and by-producing 4-hetero-oxo-heptanediol | 江苏扬农化工集团有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117986087-A | Method for preparing 1, 3-propylene glycol and by-producing 4-hetero-oxo-heptanediol | 江苏扬农化工集团有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117362152-A | Preparation method and product of 1, 3-propylene glycol | 江苏扬农化工集团有限公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-114249633-B | Method for separating and purifying 1, 3-propylene glycol | 江苏扬农化工集团有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-114276216-B | Method for removing aldehyde impurities in 1, 3-propylene glycol | 江苏扬农化工集团有限公司 | 2023-08-01 | — | — | CN | disclosed |
| US-20120190694-A1 | SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS | ALLERGAN, INC. (US) | 2012-07-26 | — | — | US | disclosed |
| EP-2464629-A1 | SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS | Allergan, Inc. (US) | 2012-06-20 | — | — | EP | disclosed |
| US-8168795-B2 | Selective sphingosine-1-phosphate receptor antagonists | ALLERGAN, INC. (US) | 2012-05-01 | — | — | US | disclosed |
| WO-2011028927-A1 | SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS | ALLERGAN, INC. (US) | 2011-03-10 | — | — | WO | disclosed |
| WO-2011019681-A1 | SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS | ALLERGAN, INC. (US) | 2011-02-17 | — | — | WO | disclosed |
| US-20110039866-A1 | SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS | ALLERGAN, INC. (US) | 2011-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190694-A1 | SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS | S1PR3, S1PR1, S1PR2 | CES2 3873/4885CES1 1465/4885FFAR4 45/4885 |
| US-20110039866-A1 | SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS | S1PR3, S1PR1, S1PR2 | CES2 3873/4885CES1 1465/4885FFAR4 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.